SREBF1 and fatty liver disease: gcn2−/− mice are protected against high-fat diet-induced hepatic steatosis by inhibiting lipogenesis and reducing oxidative stress, including srebp1c (sterol response element-binding protein 1c) and FASN (fatty acid synthase) [20].